AKBA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Akebia Therapeutics (AKBA) Earnings Date & Reports

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AKBA is expected to report earnings to fall 46.70% to -5 cents per share on May 12

Akebia Therapeutics AKBA Stock Earnings Reports

Q1'25

Est.

$-0.05

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.04

Q2'24

Beat

by $0.03

Q1'24

Missed

by $0.02

The last earnings report on March 13 showed earnings per share of -10 cents, missing the estimate of -7 cents. With 2.30M shares outstanding, the current market capitalization sits at 595.61M.

View a ticker or compare two or three

Compare

AKBA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AKBA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

245 First Street

Phone

+1 617 871-2098

Employees

167

Web

https://www.akebia.com